HUGEL

2024-10-11

ITC issues final ruling in favor of Hugel (no violation of Section 337)

The U.S. trade commission has affirmed that there was no violation of Section 337. The ITC investigation has been terminated. Hugel will accelerate its global medical aesthetics businesses as the issues are cleared up.

2024-09-23

Hugel sets sights on Indonesia with botulinum toxin Letybo

The company expands its presence in the No. 2 medical aesthetics market in Southeast Asia

2024-09-12

Hugel offers guide to safe injection of dermal fillers with DICARAT CLINIC

The seminar focused on injection skills for key facial areas and safe treatment

2024-09-09

Hugel hosts Train-The-Trainer seminar for global medical aesthetic practitioners

The program aims to improve global medical experts’ knowledge and practices for skin rejuvenation with botulinum toxin and hyaluronic acid fillers

2024-06-10

ITC final initial determination ruled in favor of Hugel (no violation of Section 337)

The trade commission says the evidence didn't support Medytox's claim of strain theft and conversion